STOCK TITAN

Macquarie reports 0% stake in Artivion (AORT) in updated 13G/A

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13G/A

Rhea-AI Filing Summary

Artivion Inc. received an updated Schedule 13G/A (Amendment No. 7) from Macquarie Group Limited, Macquarie Management Holdings Inc., and Macquarie Investment Management Business Trust regarding Artivion’s common shares. As of 12/31/2025, the Macquarie reporting entities disclose beneficial ownership of 0 common shares, representing 0.00% of the class, with no sole or shared voting or dispositive power. The filing states that the securities were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control of Artivion.

Positive

  • None.

Negative

  • None.

Insights

Macquarie’s Schedule 13G/A shows its entities now report 0% ownership of Artivion common shares.

The filing shows Macquarie Group Limited and related entities jointly reporting 0 Artivion common shares beneficially owned, equal to 0.00% of the class, as of 12/31/2025. They report no sole or shared voting or dispositive power over the shares.

The statement is made on a passive basis, certifying the securities were acquired and are held in the ordinary course of business and not to change or influence control. Subsequent ownership levels, if any, would be reflected in future beneficial ownership reports.






Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)






SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G



Macquarie Group Limited
Signature:/s/ Philip Alexander
Name/Title:Philip Alexander / Associate Director
Date:02/13/2026
Signature:/s/ Charles Glorioso
Name/Title:Charles Glorioso / Division Director
Date:02/13/2026
Macquarie Management Holdings Inc
Signature:/s/ Marty Wolin
Name/Title:Marty Wolin / Chief Compliance Officer
Date:02/13/2026
Macquarie Investment Management Business Trust
Signature:/s/ Marty Wolin
Name/Title:Marty Wolin / Chief Compliance Officer
Date:02/13/2026

FAQ

What does Macquarie’s Schedule 13G/A for Artivion (AORT) report?

Macquarie and its affiliates report owning 0 Artivion common shares. The Schedule 13G/A Amendment No. 7 states they beneficially own 0 shares, equal to 0.00% of the class, with no voting or dispositive power as of December 31, 2025.

Which Macquarie entities are reporting on Artivion (AORT) in this filing?

Three Macquarie entities jointly filed regarding Artivion. These are Macquarie Group Limited, Macquarie Management Holdings Inc., and Macquarie Investment Management Business Trust, which together report their aggregate beneficial ownership and control position in Artivion’s common shares.

How much of Artivion (AORT) does Macquarie beneficially own according to this 13G/A?

The filing shows Macquarie beneficially owns 0 Artivion shares. It lists aggregate beneficial ownership of 0.00 common shares, representing 0.00% of Artivion’s outstanding common stock, with no sole or shared voting or dispositive power reported.

What is the significance of the 0.00% ownership reported in Artivion (AORT)?

0.00% means Macquarie no longer reports a meaningful stake. Beneficial ownership of 0 shares and 0.00% indicates Macquarie and its reporting affiliates currently have no reportable ownership position in Artivion’s common stock under Schedule 13G rules.

Does Macquarie seek to influence control of Artivion (AORT) in this filing?

The filing states Macquarie is not seeking to influence control. It certifies the securities were acquired and are held in the ordinary course of business, not for changing or influencing Artivion’s control, consistent with a passive investment reporting posture.

What is the event date for Macquarie’s Artivion (AORT) ownership report?

The reported ownership position is as of December 31, 2025. The Schedule 13G/A Amendment No. 7 lists 12/31/2025 as the date of the event requiring the filing, tying the 0-share, 0.00% ownership figures to that date.
Artivion, Inc.

NYSE:AORT

AORT Rankings

AORT Latest News

AORT Latest SEC Filings

AORT Stock Data

1.93B
43.32M
4.5%
89.88%
2.32%
Medical Devices
Surgical & Medical Instruments & Apparatus
Link
United States
KENNESAW